Director/PDMR Shareholding

("Deltex Medical" or the "Company")

Directors' Shareholdings/Issue of equity

1 July 2014 - Deltex Medical Group plc, the global leader in oesophageal Doppler monitoring ("ODM"), announces that it has issued a total of 438,193 new ordinary shares of 1p each in the Company ("New Ordinary Shares") at a price of 11.38 pence per share.

The three non-executive directors named below have elected to take 262,446 New Ordinary Shares in lieu of a cash payment as remuneration for their services to the Company for the period 1 January 2014 to 30 June 2014.

A former non-executive director has elected to take 70,299 New Ordinary Shares in lieu of a cash payment as remuneration for his service to the Company for the period 1 January 2014 to 7 May 2014.

In addition to the above, the Company also announces that it has today issued a total of 105,448 New Ordinary Shares to an advisor to the Company at a price of 11.38 pence per share.

Accordingly, application has been made for these New Ordinary Shares to be admitted to trading on AIM. The shares rank pari passu with the existing issued shares of the Company. Admission to trading on AIM and dealings in the New Ordinary Shares are expected to commence on 7 July 2014. Following the issue of these new shares the Company will have a total of 213,017,689 ordinary shares of 1p each in issue.

Following this issue, the relevant directors' beneficial interests are as follows:

For further information: